TIM-3 expression is increased in CD8+ TILs in solid tumors, and correlates with poor outcome in several tumor types, among which include neck squamous cell carcinoma [170], urothelial carcinoma [171] and colorectal cancer [172]. Here, CD8A is linked to neoplasm.